Senate Bill 412 would amend the Social Welfare Act to add certain drugs to the list of drugs exempt from prior authorization requirements under Medicaid. The act provides that DHHS cannot require prior authorization for specified single source brand name, generic equivalent of a multiple source brand name, or other prescription drugs. Among those included are certain central nervous system drugs and prescription drugs recognized as effective in treatment of conditions specified in the most recent Diagnostic and Statistical Manual of Mental Disorders.